ATYR Long Call Strategy
ATYR (aTyr Pharma, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase 1b/2a clinical study for the treatment of other interstitial lung diseases (ILDs), including conditions such as chronic hypersensitivity pneumonitis and ILDs linked to connective tissue diseases. Beyond its lead candidate, aTyr Pharma's pipeline features ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical stages of development for combating fibrosis.
ATYR (aTyr Pharma, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $51.7M, a beta of 0.54 versus the broader market, a 52-week range of 0.395-7.29, average daily share volume of 2.4M, a public-listing history dating back to 2015, approximately 56 full-time employees. These structural characteristics shape how ATYR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.54 indicates ATYR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on ATYR?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current ATYR snapshot
As of June 30, 2026, spot at $0.59, ATM IV 254.30%, IV rank 27.23%, expected move 72.91%. The long call on ATYR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long call structure on ATYR specifically: ATYR IV at 254.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a ATYR long call, with a market-implied 1-standard-deviation move of approximately 72.91% (roughly $0.43 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ATYR expiries trade a higher absolute premium for lower per-day decay. Position sizing on ATYR should anchor to the underlying notional of $0.59 per share and to the trader's directional view on ATYR stock.
ATYR long call setup
The ATYR long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ATYR near $0.59, the first option leg uses a $0.59 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ATYR chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ATYR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.59 | N/A |
ATYR long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ATYR long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ATYR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on ATYR
Long calls on ATYR express a bullish thesis with defined risk; traders use them ahead of ATYR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ATYR thesis for this long call
The market-implied 1-standard-deviation range for ATYR extends from approximately $0.16 on the downside to $1.02 on the upside. A ATYR long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ATYR IV rank near 27.23% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ATYR at 254.30%. As a Healthcare name, ATYR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ATYR-specific events.
ATYR long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ATYR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ATYR alongside the broader basket even when ATYR-specific fundamentals are unchanged. Long-premium structures like a long call on ATYR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ATYR chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ATYR?
- A long call on ATYR is the long call strategy applied to ATYR (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ATYR stock trading near $0.59, the strikes shown on this page are snapped to the nearest listed ATYR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ATYR long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ATYR long call priced from the end-of-day chain at a 30-day expiry (ATM IV 254.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ATYR long call?
- The breakeven for the ATYR long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ATYR market-implied 1-standard-deviation expected move is approximately 72.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ATYR?
- Long calls on ATYR express a bullish thesis with defined risk; traders use them ahead of ATYR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ATYR implied volatility affect this long call?
- ATYR ATM IV is at 254.30% with IV rank near 27.23%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.